Guleria Mohini, Das Tapas, Vats Kusum, Amirdhanayagam Jeyachitra, Mathur Anupam, Sarma Haladhar D, Dash Ashutosh
Radiopharmaceuticals Division , Bhabha Atomic Research Centre , Trombay , Mumbai - 400085 , India . Email:
Homi Bhabha National Institute , Anushaktinagar , Mumbai - 400094 , India.
Medchemcomm. 2019 Feb 22;10(4):606-615. doi: 10.1039/c8md00559a. eCollection 2019 Apr 1.
Porphyrins are tetrapyrrolic macrocyclic ligands known for their affinity towards neoplastic tissues and once radiolabeled with a suitable diagnostic radioisotope could potentially be used for the imaging of tumorous lesions. In the present study, an unsymmetrically substituted porphyrin derivative namely 5-(-amino-propyloxyphenyl)-10,15,20-tris(carboxymethyleneoxyphenyl)-porphyrin was synthesized and modified further to enable radiolabeling with Tc using two different Tc-cores Tc-HYNIC (hydrazino nicotinic acid) and Tc(N)PNP2 (PNP2 = bis-[(2-dimethylphosphino)ethyl]-methoxy-ethylamine) in order to study the effect of employing different Tc-cores on tumor affinity and pharmacokinetic behavior of the resultant Tc-labeled porphyrin complexes. Tc-Porphyrin complexes were characterized by reversed phase HPLC studies and could be prepared with >95% radiochemical purity under optimized radiolabeling conditions. Both Tc-complexes were found to be adequately stable in human blood serum till 3 h post-preparation. Bio-distribution studies, carried out in Swiss mice bearing fibrosarcoma tumors, revealed relatively higher tumor uptake for the Tc-HYNIC-porphyrin complex (3.95 ± 1.42 and 3.28 ± 0.27% IA per g) compared to that exhibited by the Tc(N)PNP-DTC-porphyrin complex (1.52 ± 0.53 and 1.56 ± 0.10% IA per g) at 1.5 and 3 h post-administration, although the former complex exhibited comparatively lower lipophilicity in the octanol-water system. Higher uptake and longer retention in the blood were observed for the Tc-HYNIC-porphyrin complex (6.63 ± 0.75 and 4.36 ± 0.25% IA per g) compared to that exhibited by the Tc(N)PNP-DTC-porphyrin complex (2.41 ± 0.54 and 2.30 ± 0.16% IA per g) at both 1.5 and 3 h post-administration. However, relatively lower liver uptake was observed for the former complex (19.26 ± 3.48 and 18.45 ± 1.05% IA per g) than that exhibited by the latter one (39.37 ± 3.88 and 34.15 ± 8.25% IA per g) at both 1.5 and 3 h post-administration. This study indicates that the behavior exhibited by the Tc-labeled porphyrins not only depends on their lipophilicity/hydrophilicity but is also governed by the Tc-cores employed for radiolabeling.
卟啉是四吡咯大环配体,以其对肿瘤组织的亲和力而闻名,一旦用合适的诊断放射性同位素进行放射性标记,就有可能用于肿瘤病变的成像。在本研究中,合成了一种不对称取代的卟啉衍生物,即5-(-氨基-丙氧基苯基)-10,15,20-三(羧甲基氧基苯基)-卟啉,并进一步进行修饰,以便使用两种不同的锝核心——锝-HYNIC(肼基烟酸)和锝(N)PNP2(PNP2 = 双-[(2-二甲基膦基)乙基]-甲氧基乙胺)进行锝标记,以研究采用不同的锝核心对所得锝标记卟啉配合物的肿瘤亲和力和药代动力学行为的影响。通过反相高效液相色谱研究对锝-卟啉配合物进行了表征,并且在优化的放射性标记条件下可以制备出放射化学纯度>95%的配合物。发现两种锝配合物在人血清中直到制备后3小时都具有足够的稳定性。在患有纤维肉瘤肿瘤的瑞士小鼠中进行的生物分布研究表明,与锝(N)PNP-DTC-卟啉配合物(给药后1.5小时和3小时分别为1.52±0.53和1.56±0.10%IA/g)相比,锝-HYNIC-卟啉配合物在给药后1.5小时和3小时的肿瘤摄取相对较高(分别为3.95±1.42和3.28±0.27%IA/g),尽管前一种配合物在正辛醇-水体系中的亲脂性相对较低。与锝(N)PNP-DTC-卟啉配合物(给药后1.5小时和3小时分别为2.41±0.54和2.30±0.16%IA/g)相比,锝-HYNIC-卟啉配合物在给药后1.5小时和3小时的血液摄取更高且保留时间更长(分别为6.63±0.75和4.